California Retina Consultants
California Retina Consultants was paid $17.53M by Medicaid between Jan 2018 and Dec 2024, across 23 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 42% of everything it billed.
33Billing provider infoCALIFORNIA RETINA CONSULTANTS
BAKERSFIELD, CA 93309
BAKERSFIELD, CA 93309
33aNPI1083757322assigned 02/15/2007
33bProvider typeSpecialist
28Total paid$17.53M
24GClaims79,742
24DCodes billed23
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#7 of 1,230
Median peer was paid$51K
This provider vs. median341×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,048 | $344K | |
| 2019 | 6,413 | $716K | |
| 2020 | 11,726 | $1.65M | |
| 2021 | 12,268 | $1.91M | |
| 2022 | 13,529 | $3.09M | |
| 2023 | 15,646 | $4.23M | |
| 2024incomplete | 16,112 | $5.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 42% | 4,847 | 3,310 | $7.39M |
| 67028 | Intravitreal injection of a pharmacologic agent | 34% | 20,234 | 15,380 | $5.92M |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 4.5% | 1,148 | 795 | $784K |
| J2778 | Injection, ranibizumab, 0.1 mg | 4.3% | 1,907 | 1,446 | $762K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3.9% | 10,736 | 10,481 | $684K |
| 92134 | 3.8% | 19,255 | 18,618 | $674K | |
| J9035 | Injection, bevacizumab, 10 mg | 2.8% | 6,783 | 4,698 | $492K |
| 92250 | 1.1% | 4,606 | 4,474 | $201K | |
| 92235 | <1% | 1,805 | 1,786 | $157K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,328 | 3,281 | $150K |
| 67228 | <1% | 206 | 182 | $68K | |
| 92226 | <1% | 1,532 | 902 | $61K |
11 more codes
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 905 | $59K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 433 | $39K |
| J0177 | Injection, aflibercept hd, 1 mg | <1% | 14 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 359 | $18K |
| 92202 | <1% | 1,015 | $15K | |
| J3490 | Unclassified drugs | <1% | 17 | $12K |
| 92201 | <1% | 353 | $8K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 138 | $4K |
| 92225 | <1% | 54 | $3K | |
| 76512 | <1% | 51 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 16 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAVERY, ROBERT (CEO)
| Provider | Location | Paid |
|---|---|---|
| California Retina Consultants | Oxnard, CA | $3.52M |
| California Retina Consultants | Santa Maria, CA | $728K |
| California Retina Consultants | Visalia, CA | $327K |
| California Retina Consultants | Palmdale, CA | $155K |
| California Retina Consultants | San Luis Obispo, CA | $140K |
| California Retina Consultants | Paso Robles, CA | $93K |
| California Retina Consultants | Valencia, CA | $97.62 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.